Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Timothy Annett
Stay informed with Timothy Annett’s coverage and analysis for Fortune.
Health
Biogen slashes cost of Alzheimer’s drug by 50% six months after FDA approval
By
Timothy Annett
and
Bloomberg
Health
Moderna says COVID-19 vaccine for kids under 12 showed strong results
By
Timothy Annett
and
Bloomberg
Health
CureVac stock tumbles after its mRNA vaccine falls well short of Pfizer and Moderna rivals
By
Timothy Annett
,
Tim Loh
, and others
Health
Participant who died in AstraZeneca trial had not been given vaccine
By
Timothy Annett
,
Walter Brandimarte
, and others
Leadership
Juul CEO Is Stepping Down As Vaping Takes a Beating
By
Timothy Annett
and
Bloomberg
Retail
Walmart Will Stop Selling E-Cigarettes After Current Inventory Is Exhausted
By
Matthew Boyle
,
Timothy Annett
, and others
Health
Generic Drug Industry Sees New Giant as Pfizer Merges Off-Patent Unit With Mylan
By
Timothy Annett
,
Riley Ray Griffin
, and others